Literature DB >> 9747970

Expression and cellular localization of Trypanosoma cruzi type II DNA topoisomerase.

S P Fragoso1, D Mattei, J C Hines, D Ray, S Goldenberg.   

Abstract

Topoisomerases are enzymes that participate in many cellular functions involving topological manipulation of DNA strands. There are two types of topoisomerases in the cell: (a) type I topoisomerases; and (b) type II topoisomerases (topo II). Previously we have cloned and sequenced the gene encoding Trypanosoma cruzi topo II (TcTOP2). This study group has raised an antiserum against recombinant type II DNA topoisomerase (TctopoII) to study the expression of this gene during T. cruzi differentiation and to determine the cellular location of the enzyme. Western blot analysis showed that T. cruzi TctopoII is expressed in the replicative epimastigotes but not in the infective and non-replicative trypomastigotes. However, slot blot analysis of RNAs extracted from epimastigotes and metacyclic trypomastigotes showed that the mRNA encoding the enzyme is present in both developmental stages of the parasite. Confocal laser microscopy using the antiserum raised against recombinant TctopoII showed that the enzyme is located exclusively in the nucleus of the parasite. Similar results were obtained by immunofluorescence analysis of Crithidia fasciculata. However, monoclonal antisera against the corresponding enzyme extracted from C. fasciculata recognizes a kinetoplast protein in both T. cruzi and Crithidia.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9747970     DOI: 10.1016/s0166-6851(98)00066-8

Source DB:  PubMed          Journal:  Mol Biochem Parasitol        ISSN: 0166-6851            Impact factor:   1.759


  5 in total

1.  The effect of topoisomerase II inhibitors on the kinetoplast ultrastructure.

Authors:  Danielle P Cavalcanti; Stênio P Fragoso; Samuel Goldenberg; Wanderley de Souza; Maria Cristina M Motta
Journal:  Parasitol Res       Date:  2004-10-28       Impact factor: 2.289

2.  Characterisation of the gene encoding type II DNA topoisomerase from Leishmania donovani: a key molecular target in antileishmanial therapy.

Authors:  A Das; A Dasgupta; S Sharma; M Ghosh; T Sengupta; S Bandopadhyay; H K Majumder
Journal:  Nucleic Acids Res       Date:  2001-05-01       Impact factor: 16.971

3.  Cloning, functional analysis and post-transcriptional regulation of a type II DNA topoisomerase from Leishmania infantum. A new potential target for anti-parasite drugs.

Authors:  Tobias Hanke; María J Ramiro; Sonia Trigueros; Joaquim Roca; Vicente Larraga
Journal:  Nucleic Acids Res       Date:  2003-08-15       Impact factor: 16.971

Review 4.  Trypanosomatids topoisomerase re-visited. New structural findings and role in drug discovery.

Authors:  Rafael Balaña-Fouce; Raquel Alvarez-Velilla; Christopher Fernández-Prada; Carlos García-Estrada; Rosa M Reguera
Journal:  Int J Parasitol Drugs Drug Resist       Date:  2014-08-24       Impact factor: 4.077

Review 5.  Nuclear DNA Replication in Trypanosomatids: There Are No Easy Methods for Solving Difficult Problems.

Authors:  Marcelo S da Silva; Raphael S Pavani; Jeziel D Damasceno; Catarina A Marques; Richard McCulloch; Luiz Ricardo Orsini Tosi; Maria Carolina Elias
Journal:  Trends Parasitol       Date:  2017-08-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.